ARTICLE | Company News
Debiopharm receives FDA approval
July 5, 2001 7:00 AM UTC
The FDA granted marketing authorization for Debiopharm's Trelstar LA triptorelin pamoate LHRH agonist to treat advanced prostate cancer. Trelstar LA is a controlled release, intramuscular injection fo...